Skip to main content
SpringerLink
Log in

An economic analysis of spatial patterns of research and development in the pharmaceutical industry

  • Published:
The Annals of Regional Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Buchanan, William W.,Industrial Research Laboratories of the United States, Edition 12, Washington, D. C.: Bowker Associates, Inc., 1965.

    Google Scholar 

  2. Comanor, William S., “Research and Competitive Product Differentiation in the Pharmaceutical Industry in the United States,”Economica, XXXI (Nov., 1964), 372–384.

    Google Scholar 

  3. —, “Research and Technical Change in the Pharmaceutical Industry,”Review of Economics and Statistics, XLVII (May, 1965), 182–190.

    Google Scholar 

  4. —, “The Drug Industry and Medical Research: The Economics of the Kefauver Committee Investigations,”Journal of Business, XXXIX (Jan., 1966), 12–18.

    Google Scholar 

  5. Isard, Walter,Methods of Regional Analysis: An Introduction to Regional Science, Cambridge, Mass.: M. I. T. Press, 1960.

    Google Scholar 

  6. National Academy of Science, National Research Council,Industrial Research Laboratories of the United States, Editions 10 and 11, Washington, D. C.: National Academy of Sciences, 1956 and 1960.

    Google Scholar 

  7. National Science Foundation, “Basic Research, Applied Research, and Development in American Industry, 1964,”Reviews of Data on Science Resources, Jan., 1966.

  8. —,Basic Research, Applied Research, and Development in Industry, 1963, Washington, D. C.: U. S. Government Printing Office, 1966.

    Google Scholar 

  9. -, “Research Funds Used in the Nation's Scientific Endeavor, 1963,”Reviews of Research on Science Resources, I (May, 1965).

  10. Pharmaceutical Manufacturers Association,Prescription Drug Industry Fact Book (Washington, D. C.: Pharmaceutical Manufacturers Association, 1965).

    Google Scholar 

  11. 1963–1964 Plant and Product Directory of the 1000 Largest U. S. Industrial Corporations, New York: Time, Inc., 1963.

  12. Siegel, Sidney,Nonparametric Statistics for the Behavioral Sciences, New York: McGraw-Hill Book Company, Inc., 1956.

    Google Scholar 

  13. Steele, Henry, “Patent Restrictions and Price Competition in the Ethical Drugs Industry,”Journal of Industrial Economics, XII (July, 1964), 198–223.

    Google Scholar 

  14. —, “Monopoly and Competition in the Ethical Drugs Market,”Journal of Law and Economics, V (Oct., 1962), 198–223.

    Google Scholar 

  15. U. S. House of Representatives, Committee on Science and Astronautics, Subcommittee on Science, Research, and Development,Government and Science No. 4, “Geographic Distribution of Federal Research and Development Funds,” 88th Cong., 2nd Sess., 1965.

Download references

Author information

Authors and Affiliations

  1. University of Missouri, USA

    John M. Brazzel

Authors
  1. John M. Brazzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Department of Economics, University of Missouri. The research for this paper was supported by NASA Research Grant NGR-26-004-012 to the University of Missouri, Columbia, Missouri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brazzel, J.M. An economic analysis of spatial patterns of research and development in the pharmaceutical industry. Ann Reg Sci 1, 80–86 (1967). https://doi.org/10.1007/BF01290011

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01290011

Keywords

Search

Navigation